Montana Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• EMPHASIS: Minocycline Initiation Effective, Safe Within 72 Hours of Acute Ischemic Stroke
  Initiation of the multi-target anti-neuroinflammatory drug minocycline within 72 hours of acute ischemic stroke had a significant benefit in functional outcome compared to placebo, with no increased safety risks, according to findings from the EMPHASIS trial published Jan. 30 in The Lancet.
• Drug-Coated Balloons in Treating Coronary Bifurcation Lesions
  Coronary bifurcation lesions are treated in 15-20% of all percutaneous coronary intervention (PCI) cases and are a challenging scenario. Drug-eluting stents (DES) and better bifurcation PCI techniques improve the treatment of bifurcations beyond bare-metal stents, but stent thrombosis (ST) and in-stent restenosis (ISR) remain threats.
• ADVANTAGE AF Substudy: PFA vs. Standard RFA For Persistent AFib
  Cavotricuspid isthmus (CTI) ablation with a linear pulsed field ablation (PFA) catheter was associated with safety and efficacy similar to radiofrequency ablation (RFA) and greater efficiency in treating patients with persistent atrial fibrillation (AFib), based on findings from a subanalysis of the ADVANTAGE AF study published in JACC and simultaneously presented at the 31st Annual […]
• The Case For Earlier LDL Cholesterol Lowering: Supporting Lifelong Healthy Vascular Aging
  Atherosclerosis begins early and progresses silently. Patients requiring secondary prevention have already accumulated decades of low-density lipoprotein cholesterol (LDL-C) exposure resulting in some potentially irreversible arterial aging and injury.
• FDA Update: Abiomed Updates Use Instructions to Address Heart Pump Issue
  The U.S. Food and Drug Administration (FDA) has issued an Early Alert, sharing that Abiomed has updated use instructions for all Impella RP with SmartAssist and Impella RP Flex with SmartAssist devices.